Akebia Therapeutics, Inc. SEC filings AKBA
Akebia Therapeutics, Inc. has 886 filings in SEC EDGAR's recent list, going back to Apr 8, 2011. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Sep 12, 2024 | — |
| CORRESP | Letter to the SEC | Sep 10, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 9, 2024 | — |
| NT 10-Q | Filing | Aug 10, 2023 | Aug 10, 2023 |
| DEFR14A | Filing | Mar 17, 2023 | — |
| CT ORDER | Filing | Dec 13, 2022 | — |
| CT ORDER | Filing | Oct 7, 2022 | — |
| EFFECT | Filing | Apr 28, 2022 | — |
| CT ORDER | Filing | Mar 18, 2022 | — |
| POSASR | Filing | Mar 1, 2022 | — |
| CT ORDER | Filing | Dec 30, 2021 | — |
| CT ORDER | Filing | Sep 25, 2020 | — |
| CT ORDER | Filing | Jul 15, 2020 | — |
| CT ORDER | Filing | Jun 12, 2020 | — |
| CT ORDER | Filing | Apr 24, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 24, 2020 | — |
| PRER14A | Filing | Apr 15, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 19, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 6, 2020 | — |
| CT ORDER | Filing | Feb 6, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 18, 2019 | — |
| CORRESP | Letter to the SEC | Nov 5, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 26, 2019 | — |
| CT ORDER | Filing | Sep 17, 2019 | — |
| CT ORDER | Filing | Apr 30, 2019 | — |
| NT 10-K | Filing | Mar 19, 2019 | Dec 31, 2018 |
| CT ORDER | Filing | Mar 19, 2019 | — |
| 425 | Filing | Nov 30, 2018 | — |
| 425 | Filing | Nov 29, 2018 | — |
| 425 | Filing | Nov 16, 2018 | — |
| 425 | 8-k | Nov 16, 2018 | — |
| 425 | Filing | Nov 15, 2018 | — |
| 425 | Filing | Nov 13, 2018 | — |
| 425 | Filing | Nov 13, 2018 | — |
| EFFECT | Filing | Oct 30, 2018 | — |
| 425 | Filing | Oct 30, 2018 | — |
| 425 | Filing | Oct 29, 2018 | — |
| CORRESP | Letter to the SEC | Oct 29, 2018 | — |
| CORRESP | Letter to the SEC | Oct 29, 2018 | — |
| UPLOAD | Letter from the SEC | Oct 26, 2018 | — |
| CORRESP | Letter to the SEC | Oct 25, 2018 | — |
| UPLOAD | Letter from the SEC | Oct 18, 2018 | — |
| 425 | Filing | Oct 2, 2018 | — |
| 425 | 8-k | Oct 1, 2018 | — |
| 425 | Filing | Sep 14, 2018 | — |
| 425 | Filing | Sep 6, 2018 | — |
| 425 | Filing | Aug 9, 2018 | — |
| 425 | Filing | Jul 11, 2018 | — |
| 425 | Filing | Jun 28, 2018 | — |
| 425 | Filing | Jun 28, 2018 | — |
| 425 | Filing | Jun 28, 2018 | — |
| 425 | Filing | Jun 28, 2018 | — |
| 425 | Filing | Jun 28, 2018 | — |
| 425 | Filing | Jun 28, 2018 | — |
| 425 | Filing | Jun 28, 2018 | — |
| 425 | Filing | Jun 28, 2018 | — |
| 425 | Filing | Jun 28, 2018 | — |
| 425 | 8-k | Jun 28, 2018 | — |
| CT ORDER | Filing | Jun 19, 2018 | — |
| CT ORDER | Filing | Nov 28, 2017 | — |
| CT ORDER | Filing | Sep 19, 2017 | — |
| CT ORDER | Filing | Jun 29, 2017 | — |
| CT ORDER | Filing | Mar 31, 2017 | — |
| UPLOAD | Letter from the SEC | Feb 14, 2017 | — |
| CORRESP | Letter to the SEC | Jan 20, 2017 | — |
| CORRESP | Letter to the SEC | Jan 6, 2017 | — |
| UPLOAD | Letter from the SEC | Dec 22, 2016 | — |
| EFFECT | Filing | May 20, 2016 | — |
| CORRESP | Letter to the SEC | May 18, 2016 | — |
| UPLOAD | Letter from the SEC | May 17, 2016 | — |
| CT ORDER | Filing | Apr 26, 2016 | — |
| CT ORDER | Filing | Nov 17, 2015 | — |
| EFFECT | Filing | Apr 14, 2015 | — |
| CT ORDER | Filing | Mar 25, 2014 | — |
| EFFECT | Filing | Mar 19, 2014 | — |
| CERTNAS | Auto-generated paper document | Mar 19, 2014 | — |
| CORRESP | Letter to the SEC | Mar 17, 2014 | — |
| CORRESP | Letter to the SEC | Mar 17, 2014 | — |
| 8-A12B | Filing | Mar 12, 2014 | — |
| CORRESP | Letter to the SEC | Mar 4, 2014 | — |
| UPLOAD | Letter from the SEC | Mar 3, 2014 | — |
| CORRESP | Letter to the SEC | Feb 24, 2014 | — |
| DRS/A | Filing | Jan 27, 2014 | — |
| UPLOAD | Letter from the SEC | Jan 16, 2014 | — |
| DRS | Filing | Dec 20, 2013 | — |
| D/A | Filing | Apr 21, 2011 | — |
| D | Filing | Apr 8, 2011 | — |
Showing 87 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AKBA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Waltham, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1517022
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.